DSpace Repository

Highly Active Antiretroviral Therapy (HAART)–plus: next steps to enhance HAART in resource-limited areas

Show simple item record

dc.contributor.author Flanigan, Timothy P.
dc.contributor.author Kaloustain, Kara Wools
dc.contributor.author Harwell, Joseph
dc.contributor.author Cu-Uvin, Susan
dc.contributor.author Kimaiyo, Sylvester
dc.contributor.author Carter, Jane E.
dc.date.accessioned 2020-06-03T06:53:00Z
dc.date.available 2020-06-03T06:53:00Z
dc.date.issued 2007-06
dc.identifier.uri http://ir.mu.ac.ke:8080/jspui/handle/123456789/3046
dc.description.abstract HAART has been extremely successful in suppressing HIV infection, restoring im- mune function, and improving health, and it has led to dramatic decreases in morbidity and mortality in those areas of the developing world where HIV infection is most prevalent. Studies from the ART in Lower Income Countries cohort and from Malawi, Uganda, Cote de’Ivoire, and India have clearly demonstrated that 1 75% of HIV-infected individuals who re- ceive fixed-dose combination (FDC) ther- apy with a nonnucleoside reverse-tran- scriptase inhibitor have excellent viral suppression [1–5]. These successes have been outstanding and have driven the scale-up of HAART as a global health priority. More than 2 million individuals in the developing world are receiving HAART; most of these individuals are in sub-Saharan Africa, which bears the brunt of the HIV epidemic. The successful development of HIV care programs to deliver HAART faces en_US
dc.language.iso en en_US
dc.publisher Infectious Diseases Society of America en_US
dc.subject antiretroviral therapy en_US
dc.subject Resource-Limited en_US
dc.title Highly Active Antiretroviral Therapy (HAART)–plus: next steps to enhance HAART in resource-limited areas en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account